ReviewAmerican journal of hematology2021
Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist.
Review in American journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 31 citations in OpenAlex.
- Maternal and neonatal outcomes in pregnant women with severe thrombocytopenia: insights from a retrospective 8-year cohort study in China.Research and practice in thrombosis and haemostasis · 2026Article
- A rare case of pregnancy-associated thrombotic thrombocytopenic purpura.Oxford medical case reports · 2026Article
- Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal-Fetal Risks, and Management Strategies.Life (Basel, Switzerland) · 2026Review
- The Adverse Impact of Pregestational Prediabetes Contributes to HELLP Syndrome Development.Biology · 2025Article
- Severe Thrombocytopenia in Pregnancy: Etiology, Management, and Outcomes Across Platelet Count Categories.Journal of clinical medicine · 2025Article
- Recommendations of the AGG (Obstetrics and Prenatal Medicine Working Group, Section Maternal Diseases) on Maternal Thrombocytopenia in Pregnancy.Geburtshilfe und Frauenheilkunde · 2025Article
- Autoimmune Thrombocytopenia in Pregnancy: Insights from an Uncommon Case Presentation and Mini-Review.Journal of clinical medicine · 2025Review
- Case Report: Case analysis and literature review of preeclampsia complicated by inevitable abortion progressing to HELLP syndrome with liver rupture and hemorrhage.Frontiers in medicine · 2025Article
- Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis.Blood advances · 2024Article
- ADAMTS13 in the New Era of TTP.International journal of molecular sciences · 2024Review
- Understanding the complexities of space anaemia in extended space missions: revelations from microgravitational odyssey.Frontiers in physiology · 2024Article
- Labor and delivery: DIC, HELLP, preeclampsia.Hematology. American Society of Hematology. Education Program · 2023Article
- Article
- Hereditary Thrombotic Thrombocytopenic Purpura.Genes · 2023Review
- Thrombocytopenia in pregnancy.Hematology. American Society of Hematology. Education Program · 2022Review
- Special Issue "Advances in Thrombocytopenia".Journal of clinical medicine · 2022Article
- A Race against the Clock: A Case Report and Literature Review Concerning the Importance of ADAMTS13 Testing in Diagnosis and Management of Thrombotic Thrombocytopenic Purpura during Pregnancy.Diagnostics (Basel, Switzerland) · 2022Article
- Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.Blood advances · 2022Article
- Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report.Frontiers in medicine · 2022Article
- Vascular Dysfunction in Preeclampsia.Cells · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
A hematologist receives a call from a maternal-fetal medicine (MFM) physician about a previously healthy patient who became ill at 25 weeks' gestation. Her mental status is deteriorating. There are signs of fetal distress. Platelet count and hemoglobin are falling. The MFM physician is considering the hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome. For the hematologist, everything seems unfamiliar. Our goal is to provide hematologists with the fundamental knowledge required for understanding and managing these patients who become suddenly and seriously ill during pregnancy and in whom thrombocytopenia and microangiopathic hemolytic anemia are part of their presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.